{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:14:50Z","timestamp":1783995290038,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.eimc.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T14:30:19Z","timestamp":1493908219000},"page":"229-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cambio de CLSI a EUCAST en la interpretaci\u00f3n de la sensibilidad a antimicrobianos: \u00bfc\u00f3mo influye en nuestro medio?"],"prefix":"10.1016","volume":"36","author":[{"given":"Antonia","family":"S\u00e1nchez-Bautista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Coy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garc\u00eda-Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2017.03.003_bib0080","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.eimc.2015.01.019","article-title":"Comparison of clinical categories for Escherichia coli harboring specific qnr and chromosomal-mediated fluoroquinolone resistance determinants according to CLSI and EUCAST","volume":"34","author":"Machuca","year":"2016","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.eimc.2017.03.003_bib0085","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1001\/jama.2013.283828","article-title":"IDSA: Better, faster diagnostics for infectious diseases needed to curb overtreatment, antibiotic resistance","volume":"310","author":"Kuehn","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.eimc.2017.03.003_bib0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/jac\/dku336","article-title":"Using an index-based approach to assess the population-level appropriateness of empirical antibiotic therapy","volume":"70","author":"Ciccolini","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimc.2017.03.003_bib0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijmm.2015.11.004","article-title":"Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options","volume":"306","author":"Chatterjee","year":"2016","journal-title":"Int J Med Microbiol."},{"key":"10.1016\/j.eimc.2017.03.003_bib0100","doi-asserted-by":"crossref","first-page":"e79130","DOI":"10.1371\/journal.pone.0079130","article-title":"Change of antibiotic susceptibility testing guidelines from CLSI to EUCAST: Influence on cumulative hospital antibiograms","volume":"8","author":"Wolfensberger","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.eimc.2017.03.003_bib0105","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1128\/JCM.00921-13","article-title":"Influence of clinical breakpoint changes from CLSI 2009 to EUCAST 2011 antimicrobial susceptibility testing guidelines on multidrug resistance rates of Gram-negative rods","volume":"51","author":"Hombach","year":"2013","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimc.2017.03.003_bib0110","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1111\/1469-0691.12090","article-title":"The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines","volume":"19","author":"Hombach","year":"2013","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.eimc.2017.03.003_bib0115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/17512433.2016.1133286","article-title":"Optimizing antibiotic dosing strategies for the treatment of Gram-negative infections in the era of resistance","volume":"9","author":"Monogue","year":"2016","journal-title":"Expert Rev Clin Pharmacol."},{"issue":"Suppl 4","key":"10.1016\/j.eimc.2017.03.003_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0213-005X(14)70172-7","article-title":"Breakpoints for carbapenemase-producing Enterobacteriaceae: Is the problem solved?","volume":"32","author":"Cant\u00f3n","year":"2014","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.eimc.2017.03.003_bib0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/14787210.2016.1159131","article-title":"Carbapenem susceptibility breakpoints, clinical implications with the moving target","volume":"14","author":"O\u2019Donnell","year":"2016","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.eimc.2017.03.003_bib0130","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/AAC.02048-13","article-title":"Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods","volume":"58","author":"Perdig\u00e3o-Neto","year":"2014","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2017.03.003_bib0135","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae: A key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2017.03.003_bib0140","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/JCM.02424-15","article-title":"Impact of CLSI breakpoint changes on microbiology laboratories and antimicrobial stewardship programs","volume":"54","author":"Heil","year":"2016","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimc.2017.03.003_bib0145","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.eimc.2015.03.019","article-title":"Antimicrobial susceptibility cumulative reports","volume":"34","author":"Canut-Blasco","year":"2016","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.eimc.2017.03.003_bib0150","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cmi.2016.05.011","article-title":"Development of a national EUCAST challenge panel for antimicrobial susceptibility testing","volume":"22","author":"Desmet","year":"2016","journal-title":"Clin Microbiol Infect."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X17301210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X17301210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T17:24:56Z","timestamp":1530033896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X17301210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0213005X17301210"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2017.03.003","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cambio de CLSI a EUCAST en la interpretaci\u00f3n de la sensibilidad a antimicrobianos: \u00bfc\u00f3mo influye en nuestro medio?","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}